Joseph Stringer
Stock Analyst at Needham
(4.58)
# 233
Out of 5,112 analysts
324
Total ratings
49.48%
Success rate
38.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joseph Stringer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $120 → $145 | $111.73 | +29.78% | 28 | Dec 11, 2025 | |
| CDTX Cidara Therapeutics | Downgrades: Hold | n/a | $220.35 | - | 17 | Nov 14, 2025 | |
| GILD Gilead Sciences | Maintains: Buy | $133 → $140 | $121.47 | +15.25% | 9 | Nov 13, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $78 → $90 | $77.63 | +15.93% | 25 | Oct 30, 2025 | |
| RNA Avidity Biosciences | Downgrades: Hold | $65 | $72.14 | -9.89% | 19 | Oct 27, 2025 | |
| MRNA Moderna | Reiterates: Hold | n/a | $30.95 | - | 9 | Oct 20, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $22 → $35 | $31.93 | +9.61% | 24 | Oct 10, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $377 → $478 | $396.04 | +20.69% | 23 | Jul 31, 2025 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $28 | $16.28 | +71.99% | 52 | Jun 6, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $14 | $5.93 | +136.09% | 18 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $11 | $4.82 | +128.22% | 19 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $29 | $24.48 | +18.46% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $447.38 | - | 6 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $43.71 | +105.90% | 17 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.18 | - | 13 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 | $1.21 | +726.45% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $37 | $26.60 | +39.10% | 6 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $18.18 | -0.99% | 2 | Aug 24, 2021 |
Rhythm Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $111.73
Upside: +29.78%
Cidara Therapeutics
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $220.35
Upside: -
Gilead Sciences
Nov 13, 2025
Maintains: Buy
Price Target: $133 → $140
Current: $121.47
Upside: +15.25%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $78 → $90
Current: $77.63
Upside: +15.93%
Avidity Biosciences
Oct 27, 2025
Downgrades: Hold
Price Target: $65
Current: $72.14
Upside: -9.89%
Moderna
Oct 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $30.95
Upside: -
Stoke Therapeutics
Oct 10, 2025
Maintains: Buy
Price Target: $22 → $35
Current: $31.93
Upside: +9.61%
Alnylam Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $377 → $478
Current: $396.04
Upside: +20.69%
Phathom Pharmaceuticals
Jun 6, 2025
Maintains: Buy
Price Target: $28
Current: $16.28
Upside: +71.99%
Vir Biotechnology
May 22, 2025
Reiterates: Buy
Price Target: $14
Current: $5.93
Upside: +136.09%
May 13, 2025
Maintains: Buy
Price Target: $16 → $11
Current: $4.82
Upside: +128.22%
May 7, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $24.48
Upside: +18.46%
May 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $447.38
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $90
Current: $43.71
Upside: +105.90%
Mar 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.18
Upside: -
Mar 4, 2025
Downgrades: Hold
Price Target: $10
Current: $1.21
Upside: +726.45%
Jan 24, 2024
Upgrades: Buy
Price Target: $37
Current: $26.60
Upside: +39.10%
Aug 24, 2021
Maintains: Buy
Price Target: $32 → $18
Current: $18.18
Upside: -0.99%